Pay in 4 interest-free payments of $5.68 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
PubMed 22962027 TB-4 Phase 1 human safety first-in-human randomized, double-blind, single- and multiple-dose Phase 1 of recombinant human thymosin 4 in healthy volunteers, no serious adverse events: PubMed 34346165
Its value in a weight loss context is as a tissue support tool, helping maintain skin quality, hair health, and reduce inflammation during the process of losing weight, not as a cause of weight loss itself
Lesion volume was expressed as a percentage of the contralateral hemisphere volume [1]
Cat weight was 4.5 pounds at start
Both share a GHK-Cu + BPC-157 + TB-500 base
US$ 23.20
US$ 28.20
US$ 20.48
US$ 26.94
US$ 28.72
US$ 25.12
US$ 27.96
US$ 21.08
US$ 23.90
